logo
ResearchBunny Logo
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma

Medicine and Health

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma

A. Caputo, F. Nicoli, et al.

This study by Antonella Caputo and colleagues explores the acute effects of the BNT162b2 COVID-19 vaccine on severe eosinophilic asthma using an ex vivo model. The findings reveal that the vaccine enhances bronchial tone and responsiveness, offering insights into potential implications for asthmatic patients.

00:00
00:00
Playback language: English
Abstract
This study investigated the acute impact of the BNT162b2 COVID-19 vaccine on a human ex vivo model of severe eosinophilic asthma. Passively sensitized human isolated bronchi were challenged with platelet-activating factor (PAF). BNT162b2 increased resting tone and response to histamine, shifting the concentration-response curve leftward and enhancing the response to electrical field stimulation (EFS). mRNA denaturation did not alter these effects, suggesting that the effect is due to an excipient, possibly polyethylene glycol (PEG), rather than the active component.
Publisher
Vaccines
Published On
Jan 28, 2023
Authors
Antonella Caputo, Francesco Nicoli, Luigino Calzetta, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, Paola Rogliani
Tags
BNT162b2
COVID-19 vaccine
eosinophilic asthma
bronchi
histamine response
platelet-activating factor
polyethylene glycol
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny